IL6 and amyotrophic lateral sclerosis: While specific instances of hypomethylation of IL-1β, IL-6, or TNF-α promoters in ALS are still an active area of research, evidence points to broader epigenetic modification through differential methylation of immune-related regions in ALS individuals, which correlates with the spontaneous production of these cytokines.